Safety Surveillance Adviser
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Søborg
Are you passionate about ensuring the safety of pharmaceutical products? Do you have experience in safety surveillance and signal detection?
If you are ready for a new challenge and want to make a difference in the healthcare industry, read on and apply today for a life-changing career!
The Position
You will get the opportunity both to work independently and in collaboration with a team of highly skilled, committed, and enthusiastic colleagues across the functional areas in Novo Nordisk, especially the Non-clinical and Clinical Development teams. Assuming responsibility, communicating information, and taking action will be essential parts of your workday.
Responsibilities may include: Establish the product safety profile during the development and maintenance of the labeling for marketed products. Conduct safety surveillance of Novo Nordisk products during pre-approval and post-approval phases, based on safety information from worldwide sources. Communicate drug safety issues internally and to health authorities as required. Chair or participate in cross-functional safety committees, ensuring effective establishment and execution of meetings. Take responsibility for all areas related to patient safety in clinical trials. Qualifications
As an ideal candidate, you will have: A Master’s degree in Medicine or Natural Sciences (MD, DVM, MSc Pharm or equivalent). PhD is an advantage. Experience within pharmacovigilance, and/or within the pharmaceutical industry and a strong desire to specialise within safety surveillance. A solid understanding of medical concepts, scientific methodology, and drug development. The ability to work independently as well as to collaborate in a continuous developing environment.
Personally, you excel as a strong collaborator in a multicultural, continuously developing environment. You work swiftly in a high-paced environment, consistently meeting timelines. You are self-driven, capable of working independently, and effectively managing pressure when required. Ethical, responsible, well-organized, a team player, and a strong communicator describe your professional attributes.
About the Department
Safety Surveillance Obesity is a department within Global Safety at Novo Nordisk. Our dedicated and skilled professionals have global responsibility for the establishment of the product safety profile during clinical development, and for performing critical analysis and medical evaluation of the emerging aggregate safety data. Due to an increase in the number of development projects, our team is expanding.
In the Obesity department, we handle projects within the obesity and other indications from development to post-marketing. You will in collaboration with other colleagues in the department, be responsible for surveillance activities related to the compounds in development for obesity and other chronic diseases.
Working at Novo Nordisk
At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing and sales – we’re all working to move the needle on patient care.
Contact
For further information, please contact Birgitte Fischer Sode, MD, PhD Manager, Safety Surveillance Obesity & Amycretin at +4530798415.
Deadline
29 September 2024 Kindly note that applications will be reviewed continuously, and interviews conducted on a rolling basis.
Please refrain from adding a photo to your CV to ensure fair and efficient processing.
By submitting your application for this position, you acknowledge and agree that your CV and application materials may be accessible and viewed by relevant managers within our organization for the purpose of evaluating your candidacy.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
If you are ready for a new challenge and want to make a difference in the healthcare industry, read on and apply today for a life-changing career!
The Position
You will get the opportunity both to work independently and in collaboration with a team of highly skilled, committed, and enthusiastic colleagues across the functional areas in Novo Nordisk, especially the Non-clinical and Clinical Development teams. Assuming responsibility, communicating information, and taking action will be essential parts of your workday.
Responsibilities may include:
As an ideal candidate, you will have:
Personally, you excel as a strong collaborator in a multicultural, continuously developing environment. You work swiftly in a high-paced environment, consistently meeting timelines. You are self-driven, capable of working independently, and effectively managing pressure when required. Ethical, responsible, well-organized, a team player, and a strong communicator describe your professional attributes.
About the Department
Safety Surveillance Obesity is a department within Global Safety at Novo Nordisk. Our dedicated and skilled professionals have global responsibility for the establishment of the product safety profile during clinical development, and for performing critical analysis and medical evaluation of the emerging aggregate safety data. Due to an increase in the number of development projects, our team is expanding.
In the Obesity department, we handle projects within the obesity and other indications from development to post-marketing. You will in collaboration with other colleagues in the department, be responsible for surveillance activities related to the compounds in development for obesity and other chronic diseases.
Working at Novo Nordisk
At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing and sales – we’re all working to move the needle on patient care.
Contact
For further information, please contact Birgitte Fischer Sode, MD, PhD Manager, Safety Surveillance Obesity & Amycretin at +4530798415.
Deadline
29 September 2024 Kindly note that applications will be reviewed continuously, and interviews conducted on a rolling basis.
Please refrain from adding a photo to your CV to ensure fair and efficient processing.
By submitting your application for this position, you acknowledge and agree that your CV and application materials may be accessible and viewed by relevant managers within our organization for the purpose of evaluating your candidacy.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Information og data
Denne ledige stilling har jobtypen "Apoteker", og befinder sig i kategorien "Sundhed og forskning".
Arbejdsstedet er beliggende i Søborg.
Jobbet er oprettet på vores service den 22.8.2024, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Apoteker
- Søborg
Lignende jobs
-
Director, Global Regulatory Affairs - CMC
At [xxxxx], we’re committed to building extra[not]ordinary futures together, by developing antibody products and pioneering, knock-your-socks-off therapies that change the lives of patients and th..Få mere info- Apoteker
- København
-
Regulatory Affairs Specialist
Cerebriu, an award-winning health-tech startup, is at the forefront of revolutionizing the field of radiology through cutting-edge AI software. Our real-time interpretation of brain MRI images enab..Få mere info- Apoteker
- København
-
Executive Management Assistant at Xellia Pharmaceu...
Are you ready to make a difference and play a crucial role in an organization dedicated to saving lives? Are you the person who cares about making your executives everyday life work, and have you d..Få mere info- Apoteker
- København
-
Safety Operations Outsourcing Specialist
Do you have solid knowledge of drug safety/pharmacovigilance and clinical drug development, combined with project management experience? Do you have a strategic mindset and strong communication ski..Få mere info- Apoteker
- Søborg
Statistik over udbudte jobs som apotekere i Søborg
Herunder ser du udviklingen i udbudte apoteker i Søborg over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal apotekere.
Se flere statistikker her:
Statistik over udbudte apotekere i Søborg over tid
| Dato | Alle jobs som apotekere |
|---|---|
| 22. november 2024 | 2 |
| 21. november 2024 | 2 |
| 20. november 2024 | 2 |
| 19. november 2024 | 2 |
| 18. november 2024 | 1 |
| 17. november 2024 | 1 |
| 16. november 2024 | 1 |
| 15. november 2024 | 1 |
| 14. november 2024 | 1 |
| 13. november 2024 | 1 |
| 12. november 2024 | 1 |
| 11. november 2024 | 2 |
| 10. november 2024 | 2 |
| 9. november 2024 | 2 |
| 8. november 2024 | 2 |
| 7. november 2024 | 2 |
| 6. november 2024 | 2 |
| 5. november 2024 | 2 |
| 4. november 2024 | 2 |
| 3. november 2024 | 3 |
| 2. november 2024 | 3 |
| 1. november 2024 | 4 |
| 31. oktober 2024 | 4 |
| 30. oktober 2024 | 3 |
| 29. oktober 2024 | 3 |
| 28. oktober 2024 | 2 |
| 27. oktober 2024 | 3 |
| 26. oktober 2024 | 3 |
| 25. oktober 2024 | 3 |
| 24. oktober 2024 | 3 |
| 23. oktober 2024 | 3 |